RLYB Stock Analysis: Buy, Sell, or Hold?
RLYB - Rallybio Corporation Common Stock
$0.64
-0.03 (-3.86%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When RLYB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RLYB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RLYB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RLYB is currently trading at $0.64, which is considered oversold relative to its 30-day fair value range of $0.65 to $0.72.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $0.58, while resistance sits at $0.72. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: RLYB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.00 (+49.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RLYB is in a strong uptrend. Immediate support is located at $0.58, while resistance sits at $0.72. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: RLYB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.00 (+49.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.65 -
$0.72
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding RLYB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 49.7% below Wall St target ($1.00)
Fair Price Analysis
30-Day Fair Range
$0.65 -
$0.72
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.58
Resistance Level
$0.73
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.58
Wall Street Target
$1.00
(+49.7%)
Revenue Growth (YoY)
-29.1%
Last updated: January 31, 2026 8:12 AM ET
Data refreshes hourly during market hours. Next update: 9:12 AM
Data refreshes hourly during market hours. Next update: 9:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLYB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced RLYB Option Strategies
Professional options setups generated by AI based on today's RLYB price and gamma walls.
